Skip to main content
H

Hoptics

Hoptics provides a digital health platform that continuously collects physiological data from FDA‑cleared wearables and applies AI analytics to generate real real‑time risk scores and trend visualizations. The system for clinicians and patients, enabling early detection of health deviations and personalized care plans.

Mombasa, KenyaFounded 20231700+ followers
Updated 3 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Patients and clinicians often lack continuous, objective health data, making early detection of medical conditions and ongoing monitoring difficult. Traditional check-ups rely on intermittent measurements and manual interpretation, which can delay preventive interventions.

Solution

Hoptics offers a digital health platform that aggregates data from wearable sensors and applies AI-driven analytics to generate real-time, actionable health insights. The system automatically collects physiological metrics, processes them with machine-learning models, and presents clinicians and patients with clear risk indicators and trend visualizations. By delivering continuous monitoring and early warning signals, Hoptics supports proactive care decisions and more personalized treatment plans.

Target Audience

Primary users are healthcare providers—including primary care physicians and specialists—and patients seeking continuous monitoring for chronic or high‑risk conditions.

Features

  • Integration with a range of FDA‑cleared wearable sensors for continuous vital sign capture
  • AI algorithms that detect early physiological deviations and assign risk scores
  • Clinician dashboard with customizable alerts, trend charts, and patient summaries
  • Patient mobile app delivering daily health insights, recommendations, and medication reminders
  • Secure, HIPAA‑compliant data transmission and storage with end‑to‑end encryption
This profile is AI-generated and may contain inaccuracies.